These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13957747)

  • 21. Spironolactone interference with digoxin radioimmunoassay in cirrhotic patients.
    DiPiro JT; Cote JR; DiPiro CR; Bustrack JA
    Am J Hosp Pharm; 1980 Nov; 37(11):1518-21. PubMed ID: 7211855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spironolactone metabolism in normal subjects and in patients with liver cirrhosis.
    Váradi A; Fehér T; Bodrogi L; Koref O
    Arzneimittelforschung; 1977; 27(8):1618-20. PubMed ID: 578759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CLINICAL REMARKS ON THE TREATMENT OF THE ASCITES OF CIRRHOTICS BY SPIRONOLACTONE].
    MINICONI P; BOURREILLE J; CARAYON P
    Presse Med (1893); 1963 Dec; 71():2570-1. PubMed ID: 14101149
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the treatment of decompensated liver cirrhosis with spirolactone].
    NEUMAYR A; THUMB N; TRETENHAHN W
    Wien Z Inn Med; 1962 Sep; 43():375-88. PubMed ID: 13938170
    [No Abstract]   [Full Text] [Related]  

  • 25. [OUR EXPERIENCE WITH SPIROLACTONE IN THE TREATMENT OF DECOMPENSATED CIRRHOSIS].
    GEFFROY Y; DESHAYES P; FABLET J; CAYRON G
    Gaz Med Fr; 1963 Nov; 70():3205-10. PubMed ID: 14096672
    [No Abstract]   [Full Text] [Related]  

  • 26. SPIRONOLACTONE IN ASCITES OF HEPATIC CIRRHOSIS: PRELIMINARY OBSERVATIONS.
    CARPENTER CJ; MITRA P
    Bull Calcutta Sch Trop Med; 1963 Jul; 11():114-5. PubMed ID: 14068663
    [No Abstract]   [Full Text] [Related]  

  • 27. [THE SIGNIFICANCE OF DYSREGULATION CAUSED BY DIURETICS IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS].
    BRUNNER E
    Wien Klin Wochenschr; 1963 Sep; 75():674-7. PubMed ID: 14059193
    [No Abstract]   [Full Text] [Related]  

  • 28. [OUR EXPERIENCE IN THE TREATMENT OF PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS WITH ALDOSTERONE INHIBITORS].
    KNEZEVIC S; HAHN A
    Lijec Vjesn; 1963 Oct; 85():1085-93. PubMed ID: 14097613
    [No Abstract]   [Full Text] [Related]  

  • 29. SPIRONOLACTONE IN REFRACTORY ASCITES IN HEPATIC CIRRHOSIS.
    SHAH MJ; KHOKHANI RC; VAIDYA AB; SHETH UK
    J Assoc Physicians India; 1963 Oct; 11():837-42. PubMed ID: 14071784
    [No Abstract]   [Full Text] [Related]  

  • 30. [STUDY OF DIURESIS IN EDEMATOUS CIRRHOSIS].
    LAMACHE A; HUGUENIN A; VIVIEN P; RICHIER JL; MENDELL P; ROBIN J; DANRIGAL A; LEBLAY R; GUERIN D
    Sem Hop; 1964 Jun; 40():1655-64. PubMed ID: 14174422
    [No Abstract]   [Full Text] [Related]  

  • 31. [INDICATIONS FOR SPIROLACTONE IN ASCITIC CIRRHOSIS].
    CACHIN M; LEVY C
    Bull Mem Soc Med Hop Paris; 1963 Nov; 114():1243-8. PubMed ID: 14098208
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone.
    Abbas Z; Mumtaz K; Salam A; Jafri W
    J Coll Physicians Surg Pak; 2003 Jul; 13(7):382-4. PubMed ID: 12887837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urinary excretion of sodium chloride in the dog: arguments favoring the passive tubular transport of the sodium ion].
    VEREERSTRAETEN P; TOUSSAINT C
    Rev Fr Etud Clin Biol; 1962 Nov; 7():949-55. PubMed ID: 13996744
    [No Abstract]   [Full Text] [Related]  

  • 34. [OUR EXPERIENCE IN THE TREATMENT OF ASCITIC CIRRHOSIS WITH DIURETICS].
    DUBRISAY J; SCHNEIDER JJ; BOIFFIN A; MAHOUDEAU D
    Bull Mem Soc Med Hop Paris; 1963 Nov; 114():1263-9. PubMed ID: 14098210
    [No Abstract]   [Full Text] [Related]  

  • 35. [CONTRIBUTION TO THE STUDY OF THE ACTION OF TRIAMTERENE IN THE TREATMENT OF ALCOHOLIC CIRRHOSIS WITH ASCITES. (APROPOS OF 24 CASES)].
    FRAISSE H; ETAIX JP
    J Med Lyon; 1964 Jan; 45():167-72. PubMed ID: 14113139
    [No Abstract]   [Full Text] [Related]  

  • 36. "REFRACTORY" ASCITES OF CIRRHOSIS: NEWER THERAPEUTIC PROCEDURES.
    STEIGMANN F; ALVAREZ S; TRIANTAFILIDES T; DUBIN A
    Conn Med; 1964 Jan; 28():29-36. PubMed ID: 14106184
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperaldosteronism, spironolactone and liver cirrhosis].
    Sort P; Guevara M; Arroyo V
    Gastroenterol Hepatol; 1997 Mar; 20(3):151-9. PubMed ID: 9162537
    [No Abstract]   [Full Text] [Related]  

  • 38. [STUDY OF THE ASSOCIATION OF A SALT DIURETIC AND A SPIRONOLACTONE. APROPOS OF 50 OBSERVATIONS].
    MOULINIER B; TETE R; COTTON J; GIRARD M
    Lyon Med; 1964 Nov; 212():1183-206. PubMed ID: 14233311
    [No Abstract]   [Full Text] [Related]  

  • 39. [ON MODIFICATIONS OF PLASMA AND URINARY ELECTROLYTES IN ASCITOGENIC HEPATIC CIRRHOSIS IN TREATMENT WITH TRIAMTERENE ALONE AND ASSOCIATED WITH HYDROCHLOROTHIAZIDE AND WITH SPIRONOLACTONE].
    MELLONI GF; BARATTA C; MARANGONI R; MERLO L; ANTOGNETTI R
    Minerva Med; 1964 Sep; 55():2722-37. PubMed ID: 14199461
    [No Abstract]   [Full Text] [Related]  

  • 40. Opposite effects of spironolactone and amiloride on potassium excretion in a patient with ascites due to liver cirrhosis.
    Radó JP; Juhos E
    Endokrinologie; 1976 Jul; 67(3):377-9. PubMed ID: 976213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.